BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18082619)

  • 1. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
    Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
    Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
    Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
    Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
    Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geldanamycin inhibits TGF-beta signaling through induction of Hsp70.
    Yun CH; Yoon SY; Nguyen TT; Cho HY; Kim TH; Kim ST; Kim BC; Hong YS; Kim SJ; Lee HJ
    Arch Biochem Biophys; 2010 Mar; 495(1):8-13. PubMed ID: 19995547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue.
    Kim YJ; Hwang SJ; Bae YC; Jung JS
    Stem Cells; 2009 Dec; 27(12):3093-102. PubMed ID: 19816956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
    Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
    Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
    Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
    Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells.
    Zheng R; Xiong Q; Zuo B; Jiang S; Li F; Lei M; Deng C; Xiong Y
    Cell Biochem Funct; 2008; 26(5):548-56. PubMed ID: 18506886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of fibroblast growth factor-binding protein 1 repression by TGF-beta.
    Briones VR; Chen S; Riegel AT; Lechleider RJ
    Biochem Biophys Res Commun; 2006 Jun; 345(2):595-601. PubMed ID: 16690027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth.
    Park HJ; Partridge E; Cheung P; Pawling J; Donovan R; Wrana JL; Dennis JW
    Cancer Res; 2006 Apr; 66(7):3558-66. PubMed ID: 16585180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.
    Imoto S; Ohbayashi N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
    Biochem Biophys Res Commun; 2008 May; 370(2):359-65. PubMed ID: 18384750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-β-induced epithelial-mesenchymal transition.
    Li Y; Kang X; Wang Q
    J Genet Genomics; 2011 Mar; 38(3):111-6. PubMed ID: 21477782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the c-Ski oncoprotein in cell cycle arrest and transformation during nurse cell formation after Trichinella spiralis infection.
    Wu Z; Nagano I; Boonmars T; Takahashi Y
    Int J Parasitol; 2006 Sep; 36(10-11):1159-66. PubMed ID: 16890942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression.
    Malek D; Gust R; Kleuser B
    Eur J Pharmacol; 2006 Mar; 534(1-3):39-47. PubMed ID: 16497293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
    Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
    J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway.
    Anttonen M; Parviainen H; Kyrönlahti A; Bielinska M; Wilson DB; Ritvos O; Heikinheimo M
    J Mol Endocrinol; 2006 Jun; 36(3):557-68. PubMed ID: 16720723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.